Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

SHSC:6990 Stock Report

Market Cap: HK$41.2b

Sichuan Kelun-Biotech Biopharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Sichuan Kelun-Biotech Biopharmaceutical has a total shareholder equity of CN¥3.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.8B and CN¥625.5M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥2.89b
EquityCN¥3.21b
Total liabilitiesCN¥625.51m
Total assetsCN¥3.83b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 6990's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥553.8M).

Long Term Liabilities: 6990's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥71.7M).


Debt to Equity History and Analysis

Debt Level: 6990 is debt free.

Reducing Debt: 6990 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 6990 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 6990 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies